← Back to catalogue

Miracle-Ear

FDA UDI

Class II (US FDA UDI)

by WS Audiology USA, Inc.

Identity

Trade Name
Miracle-Ear FDA UDI
Generic Name
Air-conduction hearing aid, receiver-in-canal FDA UDI
Device Name
MEENERGY R 5 AX Graphite FDA UDI
Model / Reference
MEENERGY R 5 AX FDA UDI
Description
MEENERGY R 5 AX Graphite FDA UDI

Identifiers

Catalog Number
21004017 FDA UDI
Primary DI / UDI-DI
05714880135398 FDA UDI
FDA Product Code
OSM FDA UDI
KLW FDA UDI
GMDN Term
Air-conduction hearing aid, receiver-in-canal FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
874.3305 FDA UDI
874.3400 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Air-conduction hearing aid, receiver-in-canal

Miracle-Ear is a revolutionary new hearing aid designed to compensate for impaired hearing. This innovative device consists of a microphone and amplifier in a case behind-the-ear (BTE) connected via a wire, transmits amplified sound waves to the eardrum through air, and receives them electronically increased by an amplifier and sent as sound waves to the eardrum. For mild to profound hearing loss, Miracle-Ear is programmable to enable computerized adjustments for a patient's hearing loss and related factors.

Similar devices

Also classified as Air-conduction hearing aid, receiver-in-canal.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5b0169d3-7f00-4a90-8667-110b65bf8e2e 35 fields · synced Jul 24, 2026